Skip to content

NTRA · NASDAQ

Natera (NTRA) Stock Price & Fundamentals

$539.53−0.64%−$3.45End-of-day price as of Oct 9, 2026

Natera (NTRA) closed at $539.53 on Oct 9, 2026, down 0.64% from the previous close of $542.98.

Share price, past year

1Y +59.95%

52-week range $324.66 – $542.98. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$539.53
Sep 30, 2026$521.82
Aug 31, 2026$521.01
Jul 31, 2026$512.56
Jun 30, 2026$504.19
May 29, 2026$480.30
Apr 30, 2026$440.26
Mar 31, 2026$421.15
Feb 27, 2026$412.04
Jan 30, 2026$395.37
Dec 31, 2025$364.61
Nov 28, 2025$333.43
Oct 31, 2025$347.58

Key statistics

Market cap
$77.48B
P/E (TTM)
—
EPS (TTM)
−$1.35
Revenue (TTM)
$2.71B
Net income (TTM)
−$192.35M
Shares outstanding
143.6M
Dividend yield
—
52-week range
$324.66 – $542.98

Natera's market cap is $77.48B, based on a share price of $539.53 and 143.6M shares outstanding as of Jun 30, 2026.

Financials

Natera reported revenue of $2.31B for fiscal 2025, up 35.90% from fiscal 2024.

Natera reported a net loss of $208.16M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Natera annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$2.31B+35.9%−$208.16M−9.0%−$1.52$109.11M
FY2024ended Dec 31, 2024$1.70B+56.8%−$190.43M−11.2%−$1.53$69.24M
FY2023ended Dec 31, 2023$1.08B+32.0%−$434.80M−40.2%−$3.78−$286.15M
FY2022ended Dec 31, 2022$820.22M+31.1%−$547.80M−66.8%−$5.57−$479.20M
FY2021ended Dec 31, 2021$625.49M+60.0%−$471.72M−75.4%−$5.21−$376.27M
FY2020ended Dec 31, 2020$391.01M+29.3%−$229.74M−58.8%−$2.84−$202.12M
FY2019ended Dec 31, 2019$302.33M+17.3%−$124.83M−41.3%−$1.79−$68.41M
FY2018ended Dec 31, 2018$257.65M+22.2%−$128.15M−49.7%−$2.22−$74.46M
FY2017ended Dec 31, 2017$210.94M−2.8%−$137.63M−65.3%−$2.59−$107.69M
FY2016ended Dec 31, 2016$217.07M—−$100.33M−46.2%−$1.95−$97.19M
Natera quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$752.75M−$66.97M−$0.47
Q1 FY2026ended Mar 31, 2026$696.64M−$85.09M−$0.60
Q4 FY2025ended Dec 31, 2025$665.50M$47.26M$0.36
Q3 FY2025ended Sep 30, 2025$592.18M−$87.54M−$0.64
Q2 FY2025ended Jun 30, 2025$546.60M−$100.94M−$0.74
Q1 FY2025ended Mar 31, 2025$501.83M−$66.94M−$0.50
Q4 FY2024ended Dec 31, 2024$476.06M−$53.77M−$0.41
Q3 FY2024ended Sep 30, 2024$439.76M−$31.59M−$0.26

Company profile

Name
Natera, Inc.
Ticker
NTRA
Exchange
NASDAQ
Industry (SEC SIC)
Services-Medical Laboratories
Headquarters
13011 Mccallen Pass, Building A Suite 100, Austin, TX 78753
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001604821

Recent SEC filings

Frequently asked questions

What is Natera's stock price?

Natera (NTRA) closed at $539.53 on Oct 9, 2026, down 0.64% from the previous close of $542.98.

What is Natera's market cap?

Natera's market cap is $77.48B, based on a share price of $539.53 and 143.6M shares outstanding as of Jun 30, 2026.

How much revenue does Natera make?

Natera reported revenue of $2.31B for fiscal 2025, up 35.90% from fiscal 2024.

Does Natera pay a dividend?

Natera's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Natera, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures